Pages that link to "Q72709878"

The following pages link to Parametric survival analysis of adjuvant therapy for stage II breast cancer (Q72709878):

Displaying 18 items.

• Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries (Q24806397) (← links)
• Cure model analysis in cancer: an application to data from the Children's Cancer Group (Q32057033) (← links)
• Estimating Cure Rates From Survival Data: An Alternative to Two-Component Mixture Models (Q33769257) (← links)
• Parametric survival models for predicting the benefit of adjuvant chemoradiotherapy in gallbladder cancer (Q34584156) (← links)
• Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. (Q35609692) (← links)
• A finite mixture survival model to characterize risk groups of neuroblastoma (Q36024798) (← links)
• Breast Cancer Survival Analysis: Applying the Generalized Gamma Distribution under Different Conditions of the Proportional Hazards and Accelerated Failure Time Assumptions (Q36242668) (← links)
• Competing risks analyses for recurrence from primary breast cancer (Q36619117) (← links)
• Modelling survival in hepatocellular carcinoma (Q38007986) (← links)
• The case for high-dose adjuvant chemotherapy in breast cancer: (II) clinical experience (Q41326861) (← links)
• Twenty-year follow-up study of long-term survival of limited-stage small-cell lung cancer and overview of prognostic and treatment factors (Q43418874) (← links)
• Refined measurement of outcome for adjuvant breast carcinoma therapy (Q43994638) (← links)
• The case for high-dose adjuvant chemotherapy in breast cancer: (I) theoretical considerations (Q71748972) (← links)
• Alternative multivariate modelling for time to local recurrence for breast cancer patients receiving a lumpectomy alone (Q73292797) (← links)
• Short and long-term effects on survival in breast cancer patients treated by primary chemotherapy: an updated analysis of a randomized trial (Q73448963) (← links)
• Life expectancy as a measurement of the benefit shown by clinical trials of treatment for early breast cancer (Q74608437) (← links)
• Competing causes of death for primary breast cancer (Q74705645) (← links)
• End points in the analysis of breast cancer survival: relapse versus death from tumor (Q77098067) (← links)